It was recently reported that Eric Lefkofsky, CEO of Tempus, has been developing breakthroughs in precision, data-enabled medicine. With approximately 40% of US adults diagnosed with cancer sometime in their lifetime and the cancer diagnosis is expecting to approach over 19 million people by the year 2024, amazing groundbreaking companies, like Tempus, are creating better-looking prognosis.
Tempus has a goal to transform the delivery process of cancer care. They have developed a way to effectively analyze the molecular and clinical data of patients. Tempus had the means for analytics software development, but obtaining affordable medical and clinical data was an issue at first. Tempus also had to overcome the collecting and storing information process concerning cancer patients. This information was mainly in the form of doctor’s notes known as progress notes; however, these notes weren’t able to be captured and analyzed in software. Nevertheless, Tempus created software with the capability to process natural language and optical character recognition. And now the advances in technology and science made it possible for the cost of the genome to cost approximately $5,000, and it is expected to plunge to a lower price tag. Obtaining the genome used to be very expensive up to $100 million. Human genome sequencing gives clues that are beneficial against cancer, and Tempus is promoting it.
About Eric Lefkofsky
Erick Lefkofsky is the CEO and co-founder of Tempus. He is also the chairman and co-founder of Groupon, a worldwide e-commerce marketplace, and he is the founding partner of Lightbank, a venture capital fund for disruptive technologies, to name a few.
He was born in September 1969, and he is originally from Southfield, Michigan. In 1991, he graduated with high honors from the University of Michigan in Ann Arbor. In 1993, he graduated from the University of Michigan Law School earning his Juris Doctor degree. In addition to becoming a major player in the dot-com revolution, Lefkofsky held teaching positions at the Northwestern University’s Kellogg School of Management and DePaul University’s Kellstadt Graduate School of Business. Also, he is an adjunct professor at the University of Chicago’s Booth School of Business.